Pregnancy after treatment with the insulin-sensitizing agent troglitazone in an obese woman with the hyperandrogenic, insulin-resistant acanthosis nigricans syndrome

Fertility and Sterility

Volumn 71, Issue 5, 1999, Pages 943-947

  Elkind Hirsch, Karen E ^a   McWilliams, Robert B ^a  

^a MacGregor Medical Association   (United States)

Author keywords

Hyperandrogenic; Insulin resistant acanthosis nigricans (HAIR AN); Insulin sensitizing agent; Troglitazone

Indexed keywords

GLUCOSE; INSULIN; LUTEINIZING HORMONE; TROGLITAZONE;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; CASE REPORT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; NEGRO; OBESITY; PREGNANCY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ACANTHOSIS NIGRICANS; ADULT; BLOOD GLUCOSE; CHROMANS; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; OBESITY; PREGNANCY; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0033008004     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00098-9     Document Type: Article

References (9)

1. Barbieri R.L., Ryan K.J. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome a common endocrinopathy with distinct pathophysiologic feature . Am J Obstet Gynecol. 147:1993;90-101.
2. Azziz R. The hyperandrogenic-insulin resistant acanthosis nigricans syndrome therapeutic response . Fertil Steril. 61:1994;570-572.
3. Nestler J.E., Jakubowicz D.J. Decreases in ovarian cytochrome P45017 alpha activity and serum free testosterone after reduction in insulin secretion in polycystic ovary syndrome. N Engl J Med. 335:1996;617-623.
4. Velazquez E., Acosta A., Mendoza S.G. Menstrual cyclicity after metformin in polycystic ovary syndrome. Obstet Gynecol. 90:1997;392-395.
5. Nestler J.E., Jakubowicz D.J., Evans W.S., Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 338:1998;1876-1880.
6. Ehrmann D.A., Cavaghan M.K., Imperial J., Sturis J., Rosenfield R.L., Polonsky K.S. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:1997;524-530.
7. Dunaif A., Scott D., Finegood D., Quintana B., Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:1996;3299-3306.
8. Legro R.S., Finegood D., Dunaif A. A fasting glucose to insulin ration is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 83:1998;2694-2698.
9. Coetzee E.J., Jackson W.P.U. Metformin in management of pregnant insulin-dependent diabetics. Diabetologia. 16:1979;241-245.